Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Samsung to Consolidate Leadership in Mid-Premium Segment with Launch of Galaxy A55 5G, Galaxy A35 in India Technology
  • Idanim celebrates 1 year anniversary with exciting offers Business
  • Introducing The Hashtag Studios: Hyderabad’s favourite location for Pre-Wedding Shoots Lifestyle
  • A one of its kind Talent Hunt: Twinkle Twinkle Business
  • Logiciel Solutions Limited IPO Opens on November 28, 2025 Business
  • RAWLS Unveils the Exclusive “Beyond Salon” Range in Gurgaon with Jacqueline Fernandez – A New Era of Luxury in India’s Salon Industry Business
  • From Corporate Success to Educational Triumph: The Journey of Manish Bimal, Founder of Bimal Institute Education
  • UP Eyes USD 1 Trillion Gau-based Rural Economy Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Jagmohan Lal Shivratan Lal Jewellers: A Legacy of Trust and Excellence for 100+ years Business
  • SBI-SG Global Securities Services Pvt. Ltd. Spearheads CSR Initiative to Refurbish Sukh Shanti Shelter Home in Mumbai, Maharashtra Business
  • Active Clothing Co Limited Reports FY26 Performance with Total Income of Rs 318.31 Cr and PAT Growth of 19% Business
  • Inspiring story of Suresh Gurwani: a multi-talented entrepreneur & founder of Sarvatm Digital Media Services Business
  • Premium Appliances by Hafele Business
  • Vijay Sen is Perfect girls Hair stylist Business

Recent Posts

  • Bengaluru’s Scaler School of Technology is Outpacing Traditional Engineering Colleges in Placements, With Students Landing Roles at Leading Tech Firms
  • Intense Technologies Announces Retirement of Founder Mr. C.K. Shastri; Celebrates Decades of Visionary Leadership
  • Ahmed Al Maghribi Showcases the Art of Arabian Perfumery at Amazon Beautyverse
  • How to Transfer the RC After Selling Your Car: A Complete 2026 Walkthrough
  • Atlas Capital Highlights Growing Gap Between Value Creation and Market Recognition in India’s Capital Markets

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • SHARP Launches India’s First Window AC with Active Air Purification Business
  • Akhil Sachdeva makes a splendid debut in Punjabi music industry with Main Pyar Suneya Si Lifestyle
  • The third edition of the Brand Xcel Conclave is around the corner with the latest Brand Insights and Rankings Business
  • The Much-Awaited Annual Garden Sale by Shades of India is back! Business
  • Digital payments to Rural villages through QPay Business
  • Know how Jack of all Trades became an entrepreneurial master for all, 19-year-old CEO Sai Kiran Appalla Business
  • God Gift x Rishabh Pant – a new relationship with God and a twist in the tale of Hey Bhagwan! Lifestyle
  • BigBloc Construction Ltd reports Total Income of Rs. 59.12 crore in Q2FY24, growth of 21.8% Y-o-Y Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme